|
|||||
|
|
Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer |
|
| Authors: | Rochlitz Christoph Figlin Robert Squiban Patrick Salzberg Marc Pless Miklos Herrmann Richard Tartour Eric Zhao Yongxiang Bizouarne Nadine Baudin Martine Acres Bruce |
| Institution: | Department of Research, Kantonsspital Basel, Switzerland. crochlitz@uhbs.ch |
| Abstract: | |
| Keywords: | cancer gene therapy MUC1 immunotherapy vaccinia virus |
| 本文献已被 PubMed 等数据库收录！ | |